Table 3 Cox regression analysis of the clinical in LUAD patients based on various clinicopathological characteristics including EXO1 levels.
Characteristics | HR for OS (95% CI) | |
|---|---|---|
Univariate | Multivariate | |
EXO1(low vs. high) | 1.495(1.114–2.005)** | 1.476(1.049–2.078)* |
Gender (Male vs. Female) | 0.947(0.707–1.268) |  |
Clinical stage (Stage I&II vs. Stage III&IV) | 2.612(1.915–3.562)*** | 1.443(0.906–2.298) |
T stage (T1 vs. T2, T3&T4) | 1.619(1.156–2.268)** | 1.12(0.76–1.65) |
N stage (N0 vs. N1, N2&N3) | 2.478(1.849–3.32)*** | 1.513(1.014–2.259)* |
M stage (M0 vs. M1) | 2.194(1.291–3.729)** | 0.717(0.349–1.473) |
Tumor status (With tumor vs. Tumor free) | 6.414(4.38–9.393)*** | 6.121(4.134–9.062)*** |
Smoked (YES vs. NO) | 1.13(0.831–1.535) |  |
Age (> 73 vs. <=73) | 1.339(0.957–1.874) |  |